Stifel has been hit with a large penalty in an arbitration case stemming from a broker’s structured-notes strategy that has resulted in more than a dozen investor complaints.
Finra panel says Stifel was 'required to have heightened supervision' of a broker A Finra arbitration panel has ordered Stifel Financial Corp. to pay about $132 million in damages for allegedly ...
A Finra arbitration panel has ordered Stifel Financial Corp. to pay about $132 million in damages for allegedly misleading investors by pitching a product as less risky than it actually was ...
(Reuters) - Stifel Financial was ordered by a Financial Industry Regulatory Authority arbitration panel to pay a family $132.5 million for misrepresenting the risk of complex structured notes ...
Hosted on MSN1mon
Stifel maintains Buy on Iovance Biotherapeutics, target at $21O n Wednesday, Stifel analysts maintained their Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA), currently trading at $5.24, with a steady price target of $21.00. According to InvestingPro ...
(Reuters) - Stifel Financial was ordered by a Financial Industry Regulatory Authority arbitration panel to pay a family $132.5 million for misrepresenting the risk of complex structured notes, causing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results